Opus Genetics, Inc.

IRD

Chart

Market data via TradingView · delayed

Latest report

Published Sep 17, 2026

Opus Genetics (IRD): Gene Therapy Proof Against a Crowded Capital Stack

In-depth research on IRD covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.

5,711 words25 min read
Read report
Opus Genetics, Inc. (IRD) - Research & Reports | TickerFile